Northern Trust’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $9.38K | Hold |
|
|||||
|
2024
Q3 | $87.7K | Hold |
|
|||||
|
2024
Q2 | $211K | Buy |
|
|||||
|
2024
Q1 | $197K | Sell |
|
|||||
|
2023
Q4 | $311K | Buy |
|
|||||
|
2023
Q3 | $104K | Buy |
|
|||||
|
2023
Q2 | $65.3K | Hold |
|
|||||
|
2023
Q1 | $55.3K | Buy |
|
|||||
|
2022
Q4 | $54.6K | Sell |
|
|||||
|
2022
Q3 | $98K | Buy |
|
|||||
|
2022
Q2 | $93K | Sell |
|
|||||
|
2022
Q1 | $579K | Sell |
|
|||||
|
2021
Q4 | $1.71M | Buy |
|
|||||
|
2021
Q3 | $2.35M | Sell |
|
|||||
|
2021
Q2 | $3.02M | Buy |
|
|||||
|
2021
Q1 | $3.89M | Buy |
|
|||||
|
2020
Q4 | $4.9M | Sell |
|
|||||
|
2020
Q3 | $4.08M | Sell |
|
|||||
|
2020
Q2 | $5.25M | Buy |
|
|||||
|
2020
Q1 | $2.42M | Buy |
|
|||||
|
2019
Q4 | $2.77M | Sell |
|
|||||
|
2019
Q3 | $4.43M | Buy |
|
|||||
|
2019
Q2 | $3.07M | Buy |
|
|||||
|
2019
Q1 | $2.8M | Buy |
|
|||||
|
2018
Q4 | $1.71M | Buy |
|
|||||
|
2018
Q3 | $3.62M | Buy |
|
|||||
|
2018
Q2 | $2.81M | Buy |
|
|||||
|
2018
Q1 | $2.35M | Buy |
|
|||||
|
2017
Q4 | $1.3M | Sell |
|
|||||
|
2017
Q3 | $2.01M | Buy |
|
|||||
|
2017
Q2 | $935K | Buy |
|
|||||
|
2017
Q1 | $527K | Buy |
|
|||||
|
2016
Q4 | $329K | Buy |
|